A B R A H A M e t al function in mixed and pure mania. Ada Psychiatnco Scondinovico, 85. 270-274. Tlmpl, P., Spanagel, R., Sillaber, I , et al (1998) Impaired stress response and reduced anxiety in mice lacking a functional corticotropin- releasing hormone receptor 111 Oee comments]. Not Genet. 19. 162-166. Vale, W., Rlvler, C , Brown, M. R , et al (1983) Chemical and biological characterization of cor­ ticotropin releasing factor. Recent Prog Horm Res. 39, 245-270. Valentino, R. J., Foote, S. L & Page, M. E. (1993) The locus coeruleus as a site for integrating corticotropin-releasing factor and noradrenergic mediation of stress responses. Ann N Y Acad Sci. 697, 173-188. van der Leh/, A. J., Foeken, K., van der Mast, R. C , et al (1991) Rapid reversal of acute psychosis in the Cushing syndrome with the cortisol-receptor antagonist mifepristone (RU 486). Ann Intern Med, 114. 143-144. Vtota, E., Gasto, C , Martinez de Osaba, M. J , et of (1997) Prediction of depressive relapse in remitted bipolar patients using corticotrophin- releasing hormone challenge test. Acta Psychtatr Scond, 95. 205-211. Vleta, E., Martlnez-De-Osaba, M. J., Colom, F, et al (1999) Enhanced corticotropin re­ sponse to corticotropin-releasing hormone as a predictor of mania in euthymic bipolar patients. Psychotegico/ Medicine, 29. 971-978. Watson, S.. Del-Estal, D., Smith, M , et al (2001) The hypothalamic-pituitary-adrenal axis in euthymic bipolar patients. Journal of Psychophar- mocobgf, s 15. B7. Watson, S., Thompson, J. M., Ferrier, I. N , et al (2002) Association between neurocognitive and HPA axis function in euthymic bipolar patients. Bipolar Disorder, 4, 78. Webster, M. J., Knable, M. B., O'Grady, J , et al (2002) Regional specificity of brain glu­ cocorticoid receptor mRNA alterations in sub­ jects with schizophrenia and mood disorders. Mol Psychiatry, 7. 985-994, 924. Wehr, T. A . & Goodwin, F. K. (1987) Do antidepressants cause mania? Psychopharmacol Buff, 23. 61-65. Weissman, M. M., Bland, R. C , Canino, G . J , et al (1996) Cross-national epidemiology of major depression and bipolar disorder. JAMA, 276, 293-299. Whalley, L. j „ Christie, j . E., Blackwood, D. H , et al (1989) Disturbed endocrine function in the psychoses. I: Disordered homeostasis or disease process? British Journal of Psychiatry, 155, 455-461. White-Gbadebo, D. & H a m m , R. J. (1993) Chronic corticosterone treatment potentiates deficits following traumatic brain injury in rats: implications for aging. J Neurotrauma, 10, 297- 306. WolkowHz, O. M., Reus,V. I., Keebler, A , et al (1999) Double-blind treatment of major depression with dehydroepiandrosterone. Ameri­ can Journal of Psychiatry. 156, 646-649. Wolkowitz, O. M., Reus,V. I., Roberts, E., et al (1997) Dehydroepiandrosterone (DHEA) treatment of depression. Biological Psychiatry, 4 1 , 311-318. Young, A . H., Gallagher, P. A Porter, R. J. ( 2 0 0 2 a ) Elevation o f the c o r t i s o l - dehydroepiandrosterone ratio in drug-free de­ pressed patients. American Journal of Psychiatry, 159, 1237-1239. Young, A . H., Goodwin, G . M., Dick, H , et al (1994a) Effects of glucocorticoids on 5-HTIA presynaptic function in the mouse. Psychophar- macology, I 14, 360-364. Young, A . H., Sahalcian, B. J., Robbins, T. W , et al (1999) The effects of chronic administra­ tion of hydrocortisone on cognitive function in normal male volunteers. Psychopharmacology, 145. 260-266. Young, A . H., Sharpley, A . L , Campling, G. M , et al (1994b) Effects of hydrocortisone on brain 5-HT function and sleep. Journal of Affec­ tive Disorders. 32, 139-146. Young, A . H., Watson, S., Gallagher, R, et al (2002b) The effects of glucocorticoid antago­ nists in unipolar and bipolar disorders. Biological Psychiatry, 51, 83S. Young, E. A., Carlson, N . E. & Brown, M. B. (2001) Twenty-four-hour ACTH and Cortisol pulsatility in depressed w o m e n . Neuropsychopharmacology, 25, 267-276. Zarate, C . A., Jr., Tohen, M., Land, M , et of (2000) Functional impairment and cognition in bipolar disorder. Psychiatr Q, 71, 309-329. Zobel, A . W , Nickel, T., Kunzel, H . E„ et of (2000) Effects of the high-affinity corticotropin- releasing hormone receptor I antagonist R I 2 I 9 I 9 in major depression: the first 20 patients treated. Journal of Psychiatric Research. 34, 171-181. AJU ABRAHAM. MBBS, MRCPsych. Specialist Registrar in Psychiatry, *STUART WATSON, MBBS, MRCPsych, Specialist Registrar in Psychiatry; ALLAN H YOUNG, MBChB, MPhil, PhD, MRCPsych, Professor of Psychiatry, Stuartwatson@ncl.ac.uk, School of Neurology, Neurobiology and Psychiatry, Laazes Wing, Royal Victoria Infirmary, Queen Victoria Road, Newcastle upon Tyne. NEI 4LP United Kingdom, Tel: 0044 191 2824473, Fax: 0044 191 2275108 *Correspondence <•«>